Recanalization therapies in acute ischemic stroke: pharmacological agents, devices, and combinations.
The primary aim of thrombolysis in acute ischemic stroke is recanalization of an occluded intracranial artery. Recanalization is an important predictor of stroke outcome as timely restoration of regional cerebral perfusion helps salvage threatened ischemic tissue. At present, intravenously administered tissue plasminogen activator (IV-TPA) remains the only FDA-approved therapeutic agent for the treatment of ischemic stroke within 3 hours of symptom onset. Recent studies have demonstrated safety as well as efficacy of IV-TPA even in an extended therapeutic window. However, the short therapeutic window, low rates of recanalization, and only modest benefits with IV-TPA have prompted a quest for alternative approaches to restore blood flow in an occluded artery in acute ischemic stroke. Although intra-arterial delivery of the thrombolytic agent seems effective, various logistic constraints limit its routine use and as yet no lytic agent have not received full regulatory approval for intra-arterial therapy. Mechanical devices and approaches can achieve higher rates of recanalization but their safety and efficacy still need to be established in larger clinical trials. The field of acute revascularization is rapidly evolving, and various combinations of pharmacologic agents, mechanical devices, and novel microbubble/ultrasound technologies are being tested in multiple clinical trials.
Sharma
Vijay K
VK
Division of Neurology, Department of Medicine, National University Hospital, Singapore 119074.
Teoh
Hock Luen
HL
Wong
Lily Y H
LY
Su
Jie
J
Ong
Benjamin K C
BK
Chan
Bernard P L
BP
Cerebrovasc Dis. 2005;19(4):276-8
15761222
Stroke. 2008 Apr;39(4):1205-12
18309168
J Stroke Cerebrovasc Dis. 2009 Jan;18(1):23-7
19110140
Stroke. 2005 Oct;36(10):2286-8
16179581
Eur J Neurol. 2005 Jun;12(6):462-5
15885051
Stroke. 2006 May;37(5):1227-31
16574922
Ultrasound Med Biol. 2000 Jun;26(5):889-95
10942836
Stroke. 2000 Mar;31(3):601-9
10700492
Stroke. 2005 Jul;36(7):1432-8
15961709
JAMA. 1999 Dec 1;282(21):2003-11
10591382
Stroke. 2008 May;39(5):1464-9
18356546
Phys Med Biol. 2006 Aug 21;51(16):4031-45
16885622
Circulation. 1998 Sep 8;98(10):1030-5
9737524
Neurosurgery. 2002 Nov;51(5):1319-27; discussion 1327-9
12383381
JAMA. 1995 Oct 4;274(13):1017-25
7563451
Lancet. 2004 Mar 6;363(9411):768-74
15016487
Stroke. 2005 Feb;36(2):400-3
15653576
Stroke. 2005 Feb;36(2):292-6
15625300
Stroke. 2006 Apr;37(4):986-90
16527997
Stroke. 2008 May;39(5):1470-5
18340100
Thromb Haemost. 1997 Sep;78(3):1063-8
9308755
Ann Neurol. 2006 Nov;60(5):508-17
17066483
Stroke. 2007 Jul;38(7):2127-35
17525387
Ann Acad Med Singap. 2008 Sep;37(9):778-82
18989495
N Engl J Med. 2004 Nov 18;351(21):2170-8
15548777
Lancet Neurol. 2009 Feb;8(2):141-50
19097942
JAMA. 1999 Dec 1;282(21):2019-26
10591384
Stroke. 2005 Apr;36(4):880-90
15731473
Lancet. 2000 Apr 8;355(9211):1205-10
10770301
Neurology. 2007 Jan 2;68(1):39-44
17200490
Circulation. 2003 Jun 10;107(22):2837-43
12756151
Circulation. 2007 May 22;115(20):e478-534
17515473
Stroke. 1998 Jan;29(1):4-11
9445320
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2591-4
16286407
Lancet Neurol. 2008 Apr;7(4):299-309
18296121
N Engl J Med. 1995 Dec 14;333(24):1581-7
7477192
Stroke. 2005 Jul;36(7):1441-6
15947262
Stroke. 2007 Mar;38(3):967-73
17272772
Acta Neurol Scand Suppl. 2007;187:22-9
17419824
Stroke. 2005 Jan;36(1):66-73
15569863
Stroke. 2008 Jan;39(1):87-99
18032739
Stroke. 2009 Apr;40(4):1359-64
19233936
Int J Stroke. 2008 Feb;3(1):66-72
18705918
Jpn Circ J. 1999 Jun;63(6):478-84
10406589
Stroke. 2006 Apr;37(4):1000-4
16514102
Stroke. 2003 Aug;34(8):1925-31
12843342
Stroke. 2000 Apr;31(4):811-6
10753980
JAMA. 2000 May 10;283(18):2395-403
10815082
Lancet. 1998 Oct 17;352(9136):1245-51
9788453
N Engl J Med. 1995 Dec 14;333(24):1588-93
7477193
Stroke. 2004 Apr;35(4):904-11
15017018
Int J Stroke. 2009 Feb;4(1):42-8
19236498
Stroke. 2006 Feb;37(2):425-9
16373632
Stroke. 1999 Dec;30(12):2598-605
10582984
Ultrasound Med Biol. 2000 Sep;26(7):1153-60
11053750
N Engl J Med. 2008 Sep 25;359(13):1317-29
18815396